Tools / Drug approvals and letters / Drugs Furosemide Treats edema associated with congestive heart failure, cirrhosis … the nephrotic syndrome. Sold as Lasix, Furosemide, Furoscix, Furoscix Readyflow, Lasix Onyu. Every FDA application for this active ingredient: 26 branded and 47 generic.
As of Nov 13, 2026, FDA lists 73 applications for Furosemide (sold as Lasix, Furosemide, Furoscix and others), first approved Jul 1, 1966, with 6 new uses approved and 3 published complete response letters.
First approved : Jul 1, 1966 Applications : 73 New uses approved : 6 Complete response letters : 3 Medicare spending, 2024 : $147M Shortage : Current
Medicare Spending CMS Part D and Part B, 2024, before manufacturer rebates; matched by generic name Product Part Spending, 2024 Change Beneficiaries Furosemide Part D $119M -18% 5,790,198 Furoscix Part D $27.2M +217% 3,059 Lasix Part D $507K -17% 2,262 Furosemide Part B $30K -21% 16,747
Shortages FDA's drug shortage list, as of Nov 13, 2026
Applications NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history Approved Application Sponsor Supplements Marketing Jul 1, 1966 Lasix NDA 16273 · New molecular entity 36 Discontinued Mar 20, 1968 Lasix NDA 16363 · New dosage form 43 Discontinued Mar 8, 1977 Lasix NDA 17688 · New dosage form 22 Discontinued Jan 10, 1979 Furosemide NDA 18025 16 Discontinued May 19, 1981 Furosemide NDA 18267 17 Marketed Aug 27, 1981 Furosemide NDA 18487 22 Discontinued Oct 19, 1981 Furosemide NDA 18569 · New formulation or manufacturer 33 Marketed May 14, 1982 Furosemide NDA 18369 0 Discontinued May 28, 1982 Furosemide NDA 18667 18 Marketed Jul 27, 1982 Furosemide NDA 18415 17 Marketed Oct 6, 1983 Furosemide NDA 18790 25 Discontinued Nov 10, 1983 Furosemide NDA 18823 34 Marketed Nov 30, 1983 Furosemide NDA 18413 37 Discontinued Nov 30, 1983 Furosemide NDA 18579 23 Discontinued Feb 28, 1984 Furosemide NDA 18753 0 Discontinued May 22, 1984 Furosemide NDA 18902 · New formulation or manufacturer 20 Marketed Sep 26, 1985 Furosemide ANDA 70043 15 Discontinued Nov 22, 1985 Furosemide ANDA 70449 23 Discontinued Nov 22, 1985 Furosemide ANDA 70450 22 Discontinued Jan 7, 1986 Furosemide ANDA 70528 23 Discontinued Jan 24, 1986 Furosemide ANDA 70086 31 Marketed Feb 26, 1986 Furosemide ANDA 70412 10 Discontinued Feb 26, 1986 Furosemide ANDA 70413 8 Discontinued Oct 29, 1986 Furosemide ANDA 70082 19 Discontinued Dec 15, 1986 Furosemide ANDA 70017 0 Marketed Jan 2, 1987 Furosemide ANDA 71379 20 Discontinued Apr 22, 1987 Furosemide ANDA 70433 25 Marketed Apr 22, 1987 Furosemide ANDA 70434 31 Marketed Jul 8, 1987 Furosemide ANDA 70578 11 Discontinued Oct 1, 1987 Furosemide ANDA 70655 13 Discontinued Jan 26, 1988 Furosemide ANDA 70100 10 Discontinued Feb 9, 1988 Furosemide ANDA 71594 9 Discontinued Sep 14, 1990 Furosemide ANDA 71439 0 Discontinued Aug 13, 1991 Furosemide ANDA 72080 5 Discontinued Sep 16, 1994 Furosemide NDA 18750 1 Discontinued Oct 31, 1994 Furosemide ANDA 74337 1 Discontinued May 28, 1999 Furosemide ANDA 75241 4 Marketed Mar 26, 2004 Furosemide ANDA 76796 7 Marketed Nov 9, 2005 Furosemide ANDA 77293 3 Marketed Sep 18, 2006 Furosemide ANDA 78010 5 Marketed Mar 22, 2007 Furosemide ANDA 77941 1 Marketed Jan 27, 2014 Furosemide ANDA 202747 1 Marketed Apr 1, 2014 Furosemide ANDA 91258 0 Discontinued Aug 26, 2014 Furosemide ANDA 203428 2 Marketed Jul 20, 2016 Furosemide ANDA 207552 0 Discontinued May 3, 2019 Furosemide ANDA 212174 1 Marketed Jul 1, 2020 Furosemide ANDA 213902 0 Marketed Dec 18, 2020 Furosemide ANDA 208435 0 Marketed Jan 27, 2021 Furosemide ANDA 214766 0 Marketed Jan 27, 2022 Furosemide ANDA 212803 1 Marketed Oct 7, 2022 Furoscix, Furoscix Readyflow NDA 209988 · New dosage form 4 Marketed Oct 17, 2022 Furosemide ANDA 216629 0 Marketed Dec 16, 2022 Furosemide ANDA 216860 0 Marketed Apr 2, 2024 Furosemide ANDA 215856 0 Marketed Dec 13, 2024 Furosemide ANDA 217557 0 Marketed Jul 17, 2025 Furosemide ANDA 218831 0 Marketed Oct 7, 2025 Lasix Onyu NDA 217294 · New dosage form 0 Marketed Jan 8, 2026 Furosemide ANDA 218188 0 Marketed — Furosemide ANDA 70014 0 Discontinued — Furosemide ANDA 70019 0 Discontinued — Furosemide ANDA 70023 0 Discontinued — Furosemide ANDA 70078 0 Discontinued — Furosemide ANDA 70095 0 Discontinued — Furosemide ANDA 70096 0 Discontinued — Furosemide ANDA 70604 0 Discontinued — Furosemide ANDA 74017 0 Discontinued — Furosemide NDA 18370 3 Discontinued — Furosemide NDA 18419 0 Discontinued — Furosemide NDA 18420 0 Discontinued — Furosemide NDA 18507 0 Discontinued — Furosemide NDA 18670 0 Discontinued — Furosemide NDA 18868 0 Discontinued — Furosemide NDA 19036 0 Discontinued
Complete Response Letters FDA's published letters for these applications Letter Product Now Jan 12, 2024 Furosemide Product Quality Unapproved Dec 3, 2020 NDA 209988 Facility Inspections Approved Jun 11, 2018 NDA 209988 Cdrh/Device, Drug Product Quality, Clinical Approved
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
Apotex
Astrazeneca